Identification Module
The Identification Module contains basic identifying information about the clinical trial, including the NCT ID, brief title, official title, acronym, organization study ID information, and organization details. This module provides essential identifiers for the trial.
Identification Module path is as follows:
Study -> Protocol Section -> Identification Module
Identification Module
Ignite Creation Date:
2025-12-25 @ 4:01 AM
Ignite Modification Date:
2025-12-25 @ 4:01 AM
NCT ID:
NCT04799002
Brief Title:
Topotecan and Melphalan for Retinoblastoma
Official Title:
Choice of Topotecan or Melphalan in Retinoblastoma Patients
Study:
NCT04799002
Protocol Section:
NCT04799002